I would like to welcome you all to this edition of IJD: International Journal of Diabetes and Metabolism.

Diabetes is clearly attracting the major interest of researchers across the globe, and this is reflected in the fact that all the studies published in this issue are diabetes related. However, this comes as no surprise with the continuous rise in global diabetes prevalence.

I am delighted that the articles in this issue very much reflect the comprehensive approach required in diabetes. Clearly, prevention of diabetes is crucial, and the study from Nigeria addressing the impact of lifestyle measures in preventing diabetes is an interesting read.

Cardiovascular protection in diabetes is nowadays a focus point in the field of diabetes. In this issue, several studies address CVD risk factors in people with diabetes. The current management philosophy of diabetes is to treat the condition with all the risk parameters associated with it rather than a glucose-centric approach.

Type 1 diabetes (T1D) articles in this issue are also very important. For approximately 100 years the treatment of T1D was through one agent: insulin. Some recent studies have investigated adjunct therapy for T1D, and this issue includes one similar study on SGLT2I in T1D. Another study examines a common problem of diabetes: treatment adherence.

Vitamin D is currently associated with multiple health issues. Gestational diabetes prevalence in our region and globally is getting higher and higher. In this issue, we examine the role of vitamin D supplementation in patients with gestational diabetes mellitus.

Finally, I look forward to your future research articles, case reviews, editorials, and letters of communication or abstracts under the new name of the journal: Dubai Diabetes and Endocrinology Journal. We reassure you that the journal editors and team, under the new name, will work hard to match Dubai’s prestige while sustaining the international approach of the journal.

Dr. Fatheya F. Alawadi

Editor-in-chief

© 2020 The Author(s) Published by S. Karger AG, Basel
2020
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License .
Attribution-NonCommercial-NoDerivatives